PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 154 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $231,000 | +0.4% | 45,470 | +0.0% | 0.00% | – |
| Q3 2019 | $230,000 | -21.5% | 45,458 | -4.3% | 0.00% | – |
| Q2 2019 | $293,000 | +9.3% | 47,485 | -17.9% | 0.00% | – |
| Q1 2019 | $268,000 | +22.4% | 57,821 | +11.1% | 0.00% | – |
| Q4 2018 | $219,000 | -39.8% | 52,040 | -10.4% | 0.00% | -100.0% |
| Q3 2018 | $364,000 | -36.8% | 58,098 | -18.8% | 0.00% | 0.0% |
| Q2 2018 | $576,000 | +34.0% | 71,586 | +24.3% | 0.00% | 0.0% |
| Q1 2018 | $430,000 | +36.5% | 57,578 | +8.6% | 0.00% | 0.0% |
| Q4 2017 | $315,000 | -19.8% | 53,006 | -0.7% | 0.00% | 0.0% |
| Q3 2017 | $393,000 | +10.7% | 53,378 | +2.1% | 0.00% | 0.0% |
| Q2 2017 | $355,000 | -21.1% | 52,276 | +9.6% | 0.00% | 0.0% |
| Q1 2017 | $450,000 | +18.4% | 47,677 | +8.3% | 0.00% | 0.0% |
| Q4 2016 | $380,000 | – | 44,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|